Histopathological characteristics of a novel knock-in mouse prostate cancer model

AUTOR(ES)

Wu, G., Wang, D., Wang, H., Yuan, J., Xuan, J.W.

FONTE

Brazilian Journal of Medical and Biological Research

DATA DE PUBLICAÇÃO

2006-06

RESUMO

Prostate cancer is relatively unique to man. There is no naturally occurring prostate cancer in the mouse. Pre-clinical studies involve the establishment of a genetically engineered mouse prostate cancer model with features close to those of the human situation. A new knock-in mouse adenocarcinoma prostate (KIMAP) model was established, which showed close-to-human kinetics of tumor development. In order to determine if the similar kinetics is associated with heterogeneous tumor architecture similar to the human situation, we utilized a new mouse histological grading system (Gleason analogous grading system) similar to the Gleason human grading system and flow cytometry DNA analysis to measure and compare the adenocarcinoma of the KIMAP model with human prostate cancer. Sixty KIMAP prostate cancer samples from 60 mice were measured and compared with human prostate cancer. Flow cytometry DNA analysis was performed on malignant prostate tissues obtained from KIMAP models. Mice with prostate cancer from KIMAP models showed a 53.3% compound histological score rate, which was close to the human clinical average (50%) and showed a significant correlation with age (P = 0.001). Flow cytometry analyses demonstrated that most KIMAP tumor tissues were diploid, analogous to the human situation. The similarities of the KIMAP mouse model with tumors of the human prostate suggest the use of this experimental model to complement studies of human prostate cancer.

Documentos Relacionados

• Knock-In Mouse Models of Huntington's Disease
• Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy
• Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice
• Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors
• Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors